CRISPR/Cas9 instantaneous gene editing therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRISPR/Cas9 instantaneous gene editing therapy, covering 2024-06-24 to 2024-06-24. Get the full timeline:
Most recent: Clinical Trial Update: CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation [NA]